Feeds › Congressional trades
Congressional trades
Stock trades disclosed by members of the House and Senate under the STOCK Act.
About this data
- What it is
- Under the STOCK Act, members of the House and Senate must disclose stock trades over $1,000 made by themselves, their spouses and their dependent children. They report each trade as a dollar range, such as $1,001–$15,000, not an exact amount.
- Who files it
- Each member, on a periodic transaction report (PTR) filed with the House Clerk or the Senate.
- How current
- Members have up to 45 days to report a trade, so some trades appear weeks after they happened. We collect new House reports every few hours and Senate reports once a day.
- Worth knowing
- The ranges are wide, and a spouse's trade is not necessarily the member's own decision. We match assets to companies automatically, so check the filing before relying on a single row. A few rows dated after their own filing, usually a misread scan, are left out. Senate trades come from an independent public copy of the Senate's electronic filings, because the Senate's own site doesn't allow automated access. Each one links to the official report. The copy starts with reports filed in 2014, leaves out paper filings, and is missing a small share of lines, so a senator's list can be incomplete. Committee overlap describes jurisdiction only; it does not show that a trade was improper. It uses committee assignments in the 119th Congress and checks trades dated since 3 January 2025.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Trades disclosed per day, last 30 days
Purchases Sales
By the day the report was filed. The trades themselves can be up to 45 days older.
Latest congressional trades
Showing: ticker COHR
| Traded | Filed | Member | Stock | Type | AmountMembers of Congress report each trade as a dollar range, such as $1,001–$15,000, not an exact amount. | Owner | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Sep 10, 2026 | Gilbert Ray Cisneros, Jr. Democrat House · CA | COHR Coherent Corp. | Sale | $1,001 - $15,000 150 Main Street Trust > Bank of America | Member | Report ↗ |
| Jun 25, 2026 | Jul 8, 2026 | Sheldon Whitehouse Democrat Senate · RI | COHR Coherent Corp. | Purchase | $15,001 - $50,000 | Member | Report ↗ |
| Mar 25, 2026 | Apr 7, 2026 | Gilbert Ray Cisneros, Jr. Democrat House · CA | COHR Coherent Corp. | Purchase | $1,001 - $15,000 150 Main Street Trust > Bank of America | Member | Report ↗ |
| Feb 4, 2026 | Mar 2, 2026 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Sale | $15,001 - $50,000 | Joint account | Report ↗ |
| Dec 18, 2025 | Jan 13, 2026 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Sale | $15,001 - $50,000 | Spouse | Report ↗ |
| Dec 18, 2025 | Jan 13, 2026 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Sale | $15,001 - $50,000 | Member | Report ↗ |
| Oct 31, 2025 | Nov 21, 2025 | Lisa C. McClain Republican House · MI | COHR Coherent Corp. | Sale | $1,001 - $15,000 Charles Schwab 401K > Schwab 893 | Spouse | Report ↗ |
| Oct 30, 2025 | Nov 21, 2025 | Lisa C. McClain Republican House · MI | COHR Coherent Corp. | Sale | $1,001 - $15,000 Charles Schwab Brokerage Account 924 | Spouse | Report ↗ |
| Oct 30, 2025 | Nov 21, 2025 | Lisa C. McClain Republican House · MI | COHR Coherent Corp. | Purchase | $1,001 - $15,000 Charles Schwab 401K > Schwab 893 | Spouse | Report ↗ |
| Jun 17, 2025 | Aug 13, 2025 | Lisa C. McClain Republican House · MI | COHR Coherent Corp. | Purchase | $1,001 - $15,000 Charles Schwab Brokerage Account 924 | Spouse | Report ↗ |
| Feb 3, 2025 | Feb 27, 2025 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Purchase | $1,001 - $15,000 | Joint account | Report ↗ |
| Jan 2, 2025 | Jan 31, 2025 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Purchase | $15,001 - $50,000 | Member | Report ↗ |
| Jan 2, 2025 | Jan 31, 2025 | Markwayne Mullin Republican Senate · OK | COHR Coherent Corp. | Purchase | $15,001 - $50,000 | Spouse | Report ↗ |
| Dec 21, 2022 | Dec 22, 2022 | Bob Gibbs Republican House · OH | COHR Coherent Corp. | Sale | $1,001 - $15,000 CHARLES SWABB ACCOUNT | Member | Report ↗ |
| Jan 19, 2021 | Feb 3, 2021 | Earl Blumenauer Democrat House · OR | COHR Coherent, Inc. (COHR) | Sale | $1,001 - $15,000 | Spouse | Report ↗ |
| Nov 5, 2019 | Nov 6, 2019 | Bob Gibbs Republican House · OH | IIVI Coherent Corp. | Purchase | $1,001 - $15,000 CHaRLES SWaBB aCCoUNT | Member | Report ↗ |
| May 24, 2019 | Jun 21, 2019 | Bradley Scott Schneider Democrat House · IL | COHR Coherent, Inc. (COHR) | Sale | $100,001 - $250,000 16 - MSSB BROKERAGE ACCOUNT - IRA (CD/P) | Spouse | Report ↗ |
| Jan 4, 2019 | Jan 16, 2019 | Earl Blumenauer Democrat House · OR | COHR Coherent, Inc. (COHR) | Purchase | $1,001 - $15,000 | Spouse | Report ↗ |
| Jul 19, 2018 | Aug 15, 2018 | Earl Blumenauer Democrat House · OR | COHR Coherent, Inc. (COHR) | Purchase | $1,001 - $15,000 | Spouse | Report ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Committee overlap describes jurisdiction only; it does not show that a trade was improper. Based on committee assignments in the 119th Congress (since 3 January 2025). Only trades in listed companies dated since then are checked, and only clear, named jurisdictions count. Updated Nov 15, 2026, 7:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances